Amgen Net Non-Operating Interest Income Expense (Quarterly) Analysis

Amgen, Inc. (AMGN)

327.58 -2.05 (-0.62%) USD | NASDAQ | Dec 30, 11:27

View Net Non-Operating Interest Income Expense (Quarterly) for AMGN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	Upgrade
Gilead Sciences, Inc.	Upgrade
Johnson & Johnson	Upgrade
Eli Lilly & Co.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade